3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
8
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Resectable Esophageal Cancer
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Interventions
Temozolomide
6
Radiotherapy
4
Cyclophosphamide
3
TIC10 compound
2
Specimen Handling
2
Irinotecan
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Everolimus
2
Etoposide
2
Diphtheria-Tetanus Vaccine
2
tovorafenib
1
spartalizumab
1
ribociclib
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
lorlatinib
1
larotrectinib
1
gallium maltolate
1
fimepinostat
1
etoposide phosphate
1
dostarlimab
1
dipinacoline glutamate
1
dinutuximab
1
balstilimab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
abemaciclib
1
Vaccines
1
Topotecan
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Diffuse Intrinsic Pontine Glioma
×
Colony-Stimulating Factors
×
1 year
×
Clear all
No trials found.